Clinical trial
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent…
NCT00379145 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00379145 |
|---|---|
| Title | Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus |
| Official title | A Phase II Evaluation of Trabectedin (Yondelis, R279741) in the Treatment of Advanced, Persistent, or Recurrent Uterine Leiomyosarcomas |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | trabectedin |
| Enrollment | 20 |
| Start date | Jun 1, 2007 |
| Primary completion | Jan 1, 2012 |
| First posted | Sep 21, 2006 |
| Last update posted | Dec 12, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: